Sign in

CIK 0000728387

  • Non-accelerated filer
  • Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411458152
Phone
+1 206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
  1. 4 Open-market buy Controller/Prin Fin&Acct Offic bought 19,230 shares at $0.52 ($10,000)
  2. 4 Open-market buy EVP of Sales & Marketing bought 28,844 shares at $0.52 ($14,999)
  3. 4 Open-market buy Chief Financial Officer bought 67,306 shares at $0.52 ($34,999)
  4. 4 Open-market buy Chief R&D Officer bought 7,692 shares at $0.52 ($4,000)
  5. 4 Open-market buy Director bought 19,230 shares at $0.52 ($10,000)
  6. 4 Open-market buy Director bought 19,230 shares at $0.52 ($10,000)
  7. 4 Open-market buy Director bought 20,000 shares at $0.52 ($10,400)
  8. 4 Open-market buy CEO bought 48,076 shares at $0.52 ($25,000)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Exercise or conversion CEO acquired 262,500 shares (option exercise)
  20. 4 Open-market buy VP of Sales & Marketing bought 50,000 shares at $0.39 ($19,495)

Page 7 of 17 · 339 filings